Sinphar Pharmaceutical Co.,Ltd.
1734.TW
Price:
$30.5
Market Cap:
$5.80B
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products. The company also offers shampoo, body wash, tonic water, lotions, moisturizers, sunscreen lotions, and serums; and pharmaceutical packaging products, such as eye drop bottles, dry canisters, tablet bottles, and various medical grade plastic containers. In addition, it provides plant extracts and functional foods...[Read more]
Industry
Biotechnology
IPO Date
2002-08-27
Stock Exchange
TAI
Ticker
1734.TW
PE Ratio
[16.85]
ROE
[10.50%]
Current Ratio
[2.21]
Dividend Yield
[3.12%]
Enterprise Value
[6.58B]
Dividend History
The Enterprise Value as of December 2025 (TTM) for Sinphar Pharmaceutical Co.,Ltd. (1734.TW) is 6.58B
According to Sinphar Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.58B. This represents a change of 3.65% compared to the average of 6.35B of the last 4 quarters.
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Historical Enterprise Value (quarterly & annually)
How has 1734.TW Enterprise Value performed in the past?
The mean historical Enterprise Value of Sinphar Pharmaceutical Co.,Ltd. over the last ten years is 5.07B. The current 6.58B Enterprise Value has changed 12.89% with respect to the historical average. Over the past ten years (40 quarters), 1734.TW's Enterprise Value was at its highest in in the June 2024 quarter at 7.03B. The Enterprise Value was at its lowest in in the June 2018 quarter at 3.24B.
Average
5.07B
Median
5.27B
Minimum
3.62B
Maximum
6.30B
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Sinphar Pharmaceutical Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 41.89%
Maximum Annual Enterprise Value = 6.30B
Minimum Annual Increase = -20.17%
Minimum Annual Enterprise Value = 3.62B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 6.21B | -1.40% |
| 2023 | 6.30B | 5.46% |
| 2022 | 5.97B | 7.45% |
| 2021 | 5.56B | -6.69% |
| 2020 | 5.95B | 41.89% |
| 2019 | 4.20B | 16.07% |
| 2018 | 3.62B | -4.77% |
| 2017 | 3.80B | -6.90% |
| 2016 | 4.08B | -18.12% |
| 2015 | 4.98B | -20.17% |
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Average Enterprise Value
How has 1734.TW Enterprise Value performed in the past?
The current Enterprise Value of Sinphar Pharmaceutical Co.,Ltd. (1734.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.16B
5-year avg
6.00B
10-year avg
5.07B
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Enterprise Value vs. Peers
How is 1734.TW’s Enterprise Value compared to its peers?
Sinphar Pharmaceutical Co.,Ltd.’s Enterprise Value is less than OBI Pharma, Inc. (6.67B), greater than Panion & Bf Biotech Inc. (5.75B), greater than Savior Lifetec Corporation (4.26B), less than Hi-Clearance Inc. (6.82B), less than TaiGen Biopharmaceuticals Holdings Limited (8.85B), greater than Pharmosa Biopharm Inc. (6.54B), less than Locus Cell Co., Ltd. (0), greater than Pacific Hospital Supply Co., Ltd (6.17B), less than Mycenax Biotech Inc. (7.42B), greater than BioGend Therapeutics Co., Ltd. (4.59B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 6.67B | $7.27B | |
| 5.75B | $5.49B | |
| 4.26B | $5.43B | |
| 6.82B | $6.10B | |
| 8.85B | $8.83B | |
| 6.54B | $7.15B | |
| 0 | $5.77B | |
| 6.17B | $6.25B | |
| 7.42B | $6.52B | |
| 4.59B | $4.81B |
Build a custom stock screener for Sinphar Pharmaceutical Co.,Ltd. (1734.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinphar Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sinphar Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sinphar Pharmaceutical Co.,Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Sinphar Pharmaceutical Co.,Ltd. (1734.TW)?
What is the 3-year average Enterprise Value for Sinphar Pharmaceutical Co.,Ltd. (1734.TW)?
What is the 5-year average Enterprise Value for Sinphar Pharmaceutical Co.,Ltd. (1734.TW)?
How does the current Enterprise Value for Sinphar Pharmaceutical Co.,Ltd. (1734.TW) compare to its historical average?